About 5 minutes into Tuesday’s press conference describing the first U.S. Ebola diagnosis, Tom Frieden, director of the U.S. Centers…
An experimental drug that attacks brain tumor tissue by crippling mitochondria, the cells' energy source, has passed early tests in…
